Electrophysiological evidence for the tonic activation of 5-HT1A autoreceptors in the rat dorsal raphe nucleus

Neuropsychopharmacology

Volumn 29, Issue 10, 2004, Pages 1800-1806

  Haddjeri, Nasser ^a   Lavoie, Normand ^b   Blier, Pierre ^b  

^a UNIVERSITÉ LYON 1   (France)

^b ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

5 HT1A receptor; Dorsal raphe; Extracellular unitary recordings; WAY 100,635

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE DERIVATIVE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ELECTROPHYSIOLOGY; IN VIVO STUDY; MALE; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; BENZYLAMINES; CLONIDINE; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; ELECTROPHYSIOLOGY; LYSERGIC ACID DIETHYLAMIDE; MALE; NEURONS; OXIDOPAMINE; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS;

EID: 5044233152     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300489     Document Type: Article

References (54)

1. Aghajanian GK (1978). Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. In: Youdim BMH, Lovenberg W, Sharman DF, Lagnado JR (eds). Essays in Neurochemistry and Neuropharmacology. Wiley and Sons: New York. pp 2-32.
2. Anderson CD, Pasquier DA, Forbes WB, Morgane PJ (1977). Locus coeruleus to dorsal raphe input examined by electrophysiological and morphological methods. Brain Res Bull 2: 209-221.
3. Andree B, Hedman A, Thorberg SO, Nilsson D, Halldin C, Farde L (2003). Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain. Psychopharmacology 167: 37-45.
4. 1A receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing. Eur J Pharmacol 382: 133-138.
5. Baraban JM, Aghajanian GK (1980). Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19: 355-363.
6. Baraban JM, Aghajanian GK (1981). Noradrenergic innervation of serotoninergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography. Brain Res 204: 1-11.
7. Béïque JC, de Montigny C, Blier P, Debonnel G (1999). Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse 32: 198-211.
8. 1A receptor agonists in the treatment of major depression? Biol Psychiatry 53: 193-203.
9. Bortolozzi A, Artigas F (2003). Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors. Neuropsychopharmacology 28.3: 421-434.
10. 1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100,635, SDZ 216-525 and NAN-190. Pharmacol Biochem Behav 58: 593-603.
11. 3H]norarenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology 35: 63-70.
12. Clement H-W, Gemsa D, Weseman W (1992). Serotonin-norepinephrine interactions: a voltametric study on the effect of serotonin receptor stimulation followed in the nucleus raphe dorsalis and the locus coeruleus of the rat. J Neural Transm 88: 11-23.
13. 1A receptors in the rat brain. Br J Pharmacol 123: 449-462.
14. Craven R, Grahame-Smith D, Newberry N (1994). WAY 100,635 and GR127935: effects on 5-hydroxytryptamine-containing neurones. Eur J Pharmacol 271: R1-R3.
15. 1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. Eur J Pharmacol 345: 41-46.
16. De Groote L, Klompmakers AA, Olivier B, Westenberg HG (2003). Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. Psychopharmacology (Berlin) 167: 153-158.
17. Dong J, Blier P (2001). Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology 155: 52-57.
18. 1A receptor antagonist. Behav Brain Res 73: 337-353.
19. 1A agonist and antagonist drug administration in behaving cats. J Pharmacol Exp Ther 270: 1345-1358.
20. 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J Pharmacol Exp Ther 278: 752-762.
21. 1A receptor antagonist, WAY 100,635. Eur J Pharmacol 281: 81-88.
22. 2-adrenoceptors on rat central neurones. Eur J Pharmacol 105: 265-272.
23. Garrat JC, Crespi F, Mason R, Marsden CA (1991). Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function. Eur J Pharmacol 193: 349-355.
24. 1A receptors antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 115: 1064-1070.
25. Griebel G, Rodgers RJ, Perrault G, Sanger DJ (2000). The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 39: 1848-1857.
26. Grzanna R, Berger U, Fritschy JM, Geefard M (1989). Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects. J Histochem Cytochem 37: 1435-1442.
27. 1A receptor antagonist WAY 100,635 on hippocampal 5-HT release in vivo. Br J Pharmacol 112: 299P.
28. Haddjeri N, Blier P (2000). Effect of neurokinin-1 receptor antagonists on the function of 5-HT and noradrenaline neurons. NeuroReport 11: 1323-1327.
29. 2-adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J Pharmacol Exp Ther 277: 861-871.
30. Haddjeri N, de Montigny C, Blier P (1997). Modulation of the firing activity of locus coeruleus neurons in the rat by the 5-HT system. Br J Pharmacol 120: 865-875.
31. Haddjeri N, Seletti B, Gilbert F, de Montigny C, Blier P (1998). Effect of ergotamine on serotonin-mediated responses in the rodent and human brain. Neuropsychopharmacology 19: 365-380.
32. 1A receptors. Neurosci Lett 304: 129-132.
33. Hervas I, Artigas F (1998). Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur J Pharmacol 358: 9-18.
34. Hughes ZA, Stanford SC (1998). Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenaline uptake sites with different sensitivities to SSRIs. Br J Pharmacol 124: 1141-1148.
35. 1A receptors antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36: 467-473.
36. 1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 283: 216-225.
37. Johnson DA, Gartside SE, Ingram CD (2002). 5-HT(1A) receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus. Neuropharmacology 43: 959-965.
38. Jones BE, Yang T-Z (1985). The efferent projections from reticular formation and locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J Comp Neurol 242: 56-92.
39. Lanfumey L, Adrien J (1988). Adaptive changes of beta-adrenergic receptors after neonatal locus coeruleus lesion: regulation of serotoninergic unit activity. Synpase 2: 644-649.
40. Lejeune F, Millan MJ (1998). Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors- WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. Synapse 30: 172-180.
41. Logue MP, Growdon JH, Coviella IL, Wurtman RJ (1985). Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. Life Sci 37: 403-409.
42. Loizou LA (1969). Projections of the nucleus locus coeruleus in the albino rat. Brain Res 15: 563-569.
43. Luppi P-H, Aston-Jones G, Akaoka H, Chouvet G, Jouvet M (1995). Afferent projections to rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin. Neuroscience 65: 119-160.
44. Martin LP, Jackson DM, Wallsten C, Waszczak BL (1999). Electrophysiological comparison of 5-hydroxytryptamine1A receptor antagonist on dorsal raphe cell firing. J Pharmacol Exp Ther 288: 820-826.
45. 1A antagonists WAY 100,135 and WAY 100,635 on guinea-pig behaviour and dorsal raphe 5-HT neurone. Br J Pharmacol 117: 750-756.
46. Peyron C, Luppi PH, Fort P, Rampon C, Jouvet M (1996). Lower brainstem catecholamine afferents to the rat dorsal raphe nucleus. J Comp Neurol 364: 402-413.
47. Pucak ML, Grace AA (1994). Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther 271: 1171-1192.
48. 2-adrenoceptors. Synapse 50: 77-82.
49. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
50. Scuvée-Moreau JJ, Dresse AE (1979). Effect of various antidepressant drugs on the spontaneous firing rate of locus ceoruleus and dorsal raphe neurons of the rat. Eur J Pharmacol 57: 219-225.
51. Svensson TH, Bunney BS, Aghajanian GK (1975). Inhibition of both NA and 5-HT neurons in brain by the α-adrenergic agonist clonidine. Brain Res 92: 291-306.
52. Szabo ST, Blier P (2001a). Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res 922: 9-20.
53. A receptors: a microiontophoretic study in the rat locus coeruleus. Synapse 42: 203-212.
54. Ybema C, Unden F, Thorberg SO, Linder M, Kennedy S (2003). Lack of anti-depressant efficacy of the selective 5-HT1A receptor antagonist NAD-299. Results from an 8-week placebo and paroxetine-controlled study. Eur Neuropsychopharmacology 13(Suppl 4): S189.